ArticleFrontiers in aging neuroscience2026
Development and validation of a nomogram for predicting the risk of shoulder-hand syndrome after ischemic stroke: a retrospective study.
Article in Frontiers in aging neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to assess the relevant risk factors and construct a nomogram model to assist in the early identification of shoulder-hand syndrome (SHS) after ischemic stroke. Method: One thousand five hundred and thirty-nine ischemic stroke patients admitted to the First People's Hospital of Neijiang from September 2021 to August 2025 were selected as the research subjects. After exclusion, 1,211 patients were selected. These patients were divided into the training group ( Result: Multivariate Logistic regression analysis revealed that age, hypertension, alcohol drinking, muscle strength of the affected upper limb, NIHSS, albumin, and total cholesterol were independent risk factors for shoulder-hand syndrome after ischemic stroke. The nomogram model demonstrated reliable predictive efficacy, with an area under the curve (AUC value) of 0.891 (95% CI, 0.853-0.929). Both DCA and CIC confirmed that the nomogram model has strong clinical practical value. Conclusion: This study developed a novel predictive model for shoulder-hand syndrome after ischemic stroke, providing a valuable tool for the early identification of high-risk patients in clinical settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.